Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MedAdvisor Limited ( (AU:MDR) ) has provided an announcement.
MedAdvisor Limited has announced the appointment of Sean Slattery as a new director, effective August 29, 2025. This development is part of the company’s strategic efforts to strengthen its leadership team, although the newly appointed director currently holds no relevant interests in the company’s securities. This appointment is expected to enhance MedAdvisor’s governance and potentially impact its strategic direction in the healthcare technology sector.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare industry, providing digital medication management solutions. The company focuses on improving patient health outcomes through its innovative technology platform, which helps users manage their prescriptions and medication schedules more effectively.
Average Trading Volume: 974,172
Technical Sentiment Signal: Sell
Current Market Cap: A$35.01M
See more insights into MDR stock on TipRanks’ Stock Analysis page.